Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR TKIs in non-small-cell lung carcinoma

被引：0
|
作者：
Kim, H. [1 ]
Lee, S. Y. [1 ]
Choi, Y. J. [1 ]
Kim, J. S. [1 ]
Kim, S. T. [1 ]
Park, K. H. [1 ]
Shin, S. W. [1 ]
Kim, Y. H. [1 ]
机构：
[1] Korea Univ, Anam Hosp, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
704
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [41] Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer
    Chen, R.
    Zhang, X.
    Wu, Y.
    Chen, H.
    Zhou, Q.
    Su, J.
    Tu, H.
    Xie, Z.
    Zhong, W.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2225 - S2226
  • [42] EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer
    Fruh, M.
    Peters, S.
    ANNALS OF ONCOLOGY, 2019, 30 (08) : 1190 - 1192
  • [43] Metastatic non-small-cell lung cancer with EGFR mutation - case report
    Jasiowka, Marek
    Cedrych, Ida
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G46 - G48
  • [44] Relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma
    Cheng-De Wang
    Xin-Rong Wang
    Chao-Yang Wang
    Yi-Jun Tang
    Ming-Wen Hao
    Asian Pacific Journal of Tropical Medicine, 2015, (03) : 249 - 252
  • [45] Relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma
    Wang, Cheng-De
    Wang, Xin-Rong
    Wang, Chao-Yang
    Tang, Yi-Jun
    Hao, Ming-Wen
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (03) : 249 - 252
  • [46] HSP70 CAUSES EGFR-TKIS RESISTANCE IN A MUTANT EGFR EXPRESSED NON-SMALL-CELL LUNG CANCER
    Ohmori, T.
    Yamaoka, T.
    Ichihashi, Y.
    Hirose, T.
    Saijo, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 116 - 116
  • [47] Detection of EGFR mutations in circulating cell-free DNA of non-small cell lung cancer patients by next-generation sequencing
    Suzawa, Ken
    Tomida, Shuta
    Matsubara, Takahiro
    Ohashi, Kadoaki
    Maki, Yuho
    Yamamoto, Hiromasa
    Morita, Mizuki
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Kiura, Katuyuki
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    CANCER RESEARCH, 2016, 76
  • [48] Superior Outcomes of 1st Line EGFR TKI in Next-Generation Sequencing Identified Uncommon EGFR Exon 19delins Mutation Non-Small Cell Lung Cancer
    Zhang, Y.
    Yang, N.
    Jiang, T.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S409 - S410
  • [49] The advantage of targeted next-generation sequencing over qPCR in testing for druggable EGFR variants in non-small cell lung cancer
    Szpechcinski, Adam
    Moes-Sosnowska, Joanna
    Lechowicz, Urszula
    Skronska, Paulina
    Pelc, Magdalena
    Szolkowska, Malgorzata
    Wojda, Emil
    Rudzinski, Piotr
    Maszkowska-Kopij, Krystyna
    Polaczek, Mateusz
    Langfort, Renata
    Sliwinski, Pawel
    Orlowski, Tadeusz
    Chorostowska-Wynimko, Joanna
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1275 - 1275
  • [50] Cost-effectiveness of next-generation sequencing for advanced EGFR/ ALK-negative non-small cell lung cancer
    Kang, Dong-Won
    Park, Sun-Kyeong
    Kang, Sokbom
    Lee, Eui-Kyung
    LUNG CANCER, 2024, 197
12345